Gene Therapy

Doaa Hashad

ISBN 10: 9535122215 / ISBN 13: 9789535122210

Published by Intechopen Nov 2015, 2015

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Gene therapy is becoming a promising technology for the management of many human diseases. Hereditary and acquired disorders can both be tackled using the technique of gene therapy. This book provides detailed, up-to-date topics addressing basic principles of gene therapy and discussing some of the challenges encountered by scientists in developing this relatively novel technology. The development of new and efficient gene transfer vectors is of utmost importance in the progress of the field of gene therapy. Both viral and non-viral vectors are extensively discussed. A detailed chapter elaborates the problem of host immune rejection of transplanted donor cells or engineered tissue that can be avoided using the encapsulation of transgenic cells, thus avoiding the use of drugs that achieve immunosuppression. 218 pp. Englisch.

Seller Inventory # 9789535122210

Bibliographic Details

• Title: Gene Therapy
• Publisher: Intechopen Nov 2015
• Publication Date: 2015
• Language: English
• ISBN 10: 9535122215
• ISBN 13: 9789535122210
• Binding: Buch
• Condition: Neu
• Dimensions: 266W x 185H x 20D millimeters 266 millimeters width by 185 millimeters height by 20 millimeters depth
• Weight: 689 grams

About this title

Synopsis

Gene therapy is becoming a promising technology for the management of many human diseases. Hereditary and acquired disorders can both be tackled using the technique of gene therapy. This book provides detailed, up-to-date topics addressing basic principles of gene therapy and discussing some of the challenges encountered by scientists in developing this relatively novel technology. The development of new and efficient gene transfer vectors is of utmost importance in the progress of the field of gene therapy. Both viral and non-viral vectors are extensively discussed. A detailed chapter elaborates the problem of host immune rejection of transplanted donor cells or engineered tissue that can be avoided using the encapsulation of transgenic cells, thus avoiding the use of drugs that achieve immunosuppression.